AVGO vs INTT
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Broadcom exhibits a dichotomy between elite operational performance and poor deterministic value metrics. While the Piotroski F-Score of 4/9 indicates stable health, the stock trades at a massive premium to its Graham Number ($44.08) and Intrinsic Value ($151.04). This valuation gap is partially justified by a very attractive PEG ratio (0.68) and strong forward P/E (19.65), suggesting high growth expectations. However, aggressive insider selling by the CEO and CFO, combined with a bearish technical trend, offsets the strong analyst 'strong_buy' consensus.
INTT exhibits a severe divergence between its market price and fundamental health, highlighted by a weak Piotroski F-Score of 2/9. While the stock has seen a massive 167.8% price increase over the last year, this rally is unsupported by deteriorating fundamentals, including negative YoY revenue growth (-10.30%) and negative earnings growth (-19.70%). The company is currently unprofitable with a negative ROE and profit margin, and insider activity is bearish with the CEO selling shares. The current valuation appears speculative and disconnected from the company's operational decline.
Compare Another Pair
Related Comparisons
AVGO vs INTT: Head-to-Head Comparison
This page compares Broadcom Inc. (AVGO) and InTest Corporation (INTT) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.